Skip to main content
. 2022 Sep 27;12:1014156. doi: 10.3389/fonc.2022.1014156

Figure 1.

Figure 1

CTLA-4 mechanism for T-cell regulation. The figure illustrates the relation of CTLA-4 with Tryptophan catabolization, Cbl, ZAP-70, and PI3K pathways leading to inhibition of T-cell proliferation and activation and inhibited immune response against tumor. In cancer immunotherapy, CTLA-R receptor was the first receptor to be targeted clinically. Blockade of this receptor by antibodies prevent its interaction in immune system inhibition.